ClinicalTrials.gg
CompletedNCT00961428Updated Dec 5, 2012

Motivation to Exercise in People With Anorexia Nervosa

An observational study in Anorexia Nervosa, sponsored by New York State Psychiatric Institute. Completed at 1 site in United States. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2012-12-05.

Sponsored by New York State Psychiatric Institute · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
60
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The purpose of this research study is to determine the importance and level of physical activity in people with Anorexia Nervosa.

Read the detailed description

A laboratory paradigm that uses a progressive ratio computerized work task will be used to determine the reinforcing value of exercise in hospitalized patients with AN, both before and after weight gain. In addition, we will examine the relationship between the reinforcing value of exercise and free-living physical activity in this population. We will also examine the relationship between the reinforcing value of exercise and measures of depression, anxiety, and cortisol, which we have found in previous studies to be associated with other measures of physical activity and exercise motivation. In order to determine whether physical activity in women with AN differs from that of non-eating disordered women, we will extend studies of physical activity to free-living control participants. All adult patients and controls will undergo body composition assessment once to measure the association between physical activity and percent body fat. Finally, to determine the impact of exercise reinforcement and physical activity on outcome in women with AN, we will conduct follow-up assessments in all patient participants for one year after discharge from the inpatient treatment unit."

02

Conditions studied

  • Anorexia Nervosa

Keywords

  • Anorexia Nervosa
  • Eating Disorders
  • Exercise
  • Physical Activity
03

In context

Anorexia Nervosa

462 studies on the registry are indexed under Anorexia Nervosa; 127 are open to participants now.

This study's enrollment of 60 is below the median of 70 across 136 observational studies indexed under Anorexia Nervosa.

Browse Anorexia Nervosa studies →

Lead sponsor

New York State Psychiatric Institute is the lead sponsor of 433 studies on the registry; 25 are open to participants now.

Of its 50 completed or terminated interventional studies of FDA-regulated products, 45 (90%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Participants will be patients with anorexia nervosa on the inpatient unit at New York State Psychiatric Institute

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • DSM-IV diagnosis of Anorexia Nervosa (except amenorrhea)
  • Female
  • Age 18-45
  • Medically Stable for exercise participation
  • At a minimum of 75% Ideal Body Weight

Exclusion criteria

Exclusion Criteria:

  • Significant or current past medical illness including diabetes mellitis and heart disease
  • Current or lifetime history or schizophrenia, bipolar disorder, or other psychotic disorder as defined by DSM-IV-TR
  • Current suicidal ideation or recent suicidal behavior (within past 3 months)
  • Drug or alcohol abuse in last 6 months
  • Taking psychotropic medication
  • Pregnancy
05

Study design

Time perspective
Prospective
Enrollment
60 participants (actual)
Biospecimen retention
Samples without dna
06

What researchers measure

Primary outcomes

  1. physical activity

    Time frame: Physical activity before and after weight restoration

07

Study locations

1 site
  • New York State Psychiatric Institute
    New York, New York 10032, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2007, a primary completion of Jul 2011 and a completion of Jul 2011. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2009
First posted
Aug 19, 2009
Start
Dec 2007
Primary completionActual
Jul 2011
CompletionActual
Jul 2011
Last update
Dec 5, 2012
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 5, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00961428
Responsible party
Sponsor
First posted
Aug 19, 2009
Start date
Dec 2007
Primary completion
Jul 2011
Completion
Jul 2011
Last update
Dec 5, 2012

Study contacts

B. Timothy Walsh, MD
study director · NYSPI
Evelyn Attia, MD
principal investigator · NYSPI

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion